Vascular Disorder clinical trials
20 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- CLOSM Trial: Groin Closure Using Layered Option for Suture Material
- Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support
- Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU
- Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients
- Potassium, Hydration, Cardiovascular, and Kidney Study (PHACKs)
- Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
- Mechanisms of Pregnancy Vascular Adaptations
- Vascular Disease Discovery Protocol
- Thrombosis and Inflammation in Vessels Initiative (TIVI)
- Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies
- The RADIANCE CED Study
- Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation
- Factors Affect Outcomes in Cardiovascular Surgery
- Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
- Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters
- SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery
- Collecting Data on Retinal Blood Blood Flow and Blood Vessel Shape/Appearance Using an Investigational Device, XyCAM CRE, and to Then Compare Those Images With Images Collected From a Patient's Routine Clinical Examination.
- Evaluation of Accelerated Sampling Techniques for Vessel Wall Imaging
- Health eHeart BioBank
- Improving Blood Pressure Control in Stroke Patients by Increasing Access to a Home Blood Pressure Monitor
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Vascular Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.